Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC–MS/MS and bioinformatics analysis

2017 ◽  
Vol 86 ◽  
pp. 17-24 ◽  
Author(s):  
Juanjuan Ren ◽  
Guoqing Zhao ◽  
Xiujia Sun ◽  
Hongmei Liu ◽  
Ping Jiang ◽  
...  
2021 ◽  
pp. 113842
Author(s):  
Qinglai Bian ◽  
Jianbei Chen ◽  
Jiajia Wu ◽  
Fengmin Ding ◽  
Xiaojuan Li ◽  
...  

2014 ◽  
Vol 16 (4) ◽  
pp. 378-388 ◽  
Author(s):  
Martin J Lan ◽  
Binod Thapa Chhetry ◽  
Maria A Oquendo ◽  
M Elizabeth Sublette ◽  
Gregory Sullivan ◽  
...  

2020 ◽  
Vol 277 ◽  
pp. 620-630
Author(s):  
Yachen Shi ◽  
Ruize Song ◽  
Liping Wang ◽  
Yangjian Qi ◽  
Hongxing Zhang ◽  
...  

2020 ◽  
Vol 269 ◽  
pp. 43-50 ◽  
Author(s):  
Can Zeng ◽  
Zhimin Xue ◽  
Brendan Ross ◽  
Manqi Zhang ◽  
Zhening Liu ◽  
...  

CNS Spectrums ◽  
2016 ◽  
Vol 21 (2) ◽  
pp. 123-127 ◽  
Author(s):  
Stephen M. Stahl

Cariprazine is a new therapeutic agent recently approved for the treatment of both schizophrenia and manic or mixed episodes associated with bipolar disorder, and is under investigation for the treatment of both bipolar depression and major depressive disorder.


Sign in / Sign up

Export Citation Format

Share Document